Guided Therapeutics (GTHP) Preferred Shares Issued (2015 - 2021)

Guided Therapeutics has disclosed Preferred Shares Issued across 2 years of filings, most recently posting $1.3 million for Q4 2021.

• Preferred Shares Issued for Q4 2021 came in at $1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $1.3 million (up 948.8% YoY), and the FY2021 annual result was $1.4 million, changed N/A from the prior year.
• Preferred Shares Issued came in at $1.3 million for Q4 2021 at Guided Therapeutics, up from -$1.3 million in the prior quarter.
• In the past five years, Preferred Shares Issued ranged from a high of $1.8 million in Q1 2021 to a low of -$1.3 million in Q3 2021.